Velev, M., Baroudjian, B., Pruvost, R., De Martin, E., Laparra, A., Babai, S., Teysseire, S., Danlos, F., Albiges, L., Bernigaud, C., Benderra, M., Pradère, P., Zaidan, M., Decroisette, C., Fallah, F., Matergia, G., Lavaud, P., Jantzem, H., Atzenhoffer, M., Buyse, V., Ammari, S., Robert, C., Champiat, S., Messayke, S., Marabelle, A., Guettier, C., Lebbe, C., Lambotte, O., & Michot, J. (2023). immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors. European journal of cancer, 179, 28–47. http://access.bl.uk/ark:/81055/vdc_100173102040.0x00002a